Alkermes plc

ALKS

Market Cap$4.23B

Close$

Compare Alkermes plc

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Alkermes plc	11.9	0%	30%	2.7	0.2
Market Avg	59.7	1.27%	30%	-	0.9
Healthcare Avg	64.5	1.29%	15%	7.1	0.8

$36.75

Target Price by Analysts

53.1% upsideAlkermes plc Target Price Details

$17.58

Current Fair Value

26.8% downside

Overvalued by 26.8% based on the discounted cash flow analysis.

Share Statistics

Market cap	$4.23 Billion
Enterprise Value	$3.75 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$2.1
Beta	0.0
Outstanding Shares	169,184,183
Avg 30 Day Volume	2,337,983

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	11.88
PEG	-2.38
Price to Sales	2.67
Price to Book Ratio	3.43
Enterprise Value to Revenue	2.25
Enterprise Value to EBIT	9.04
Enterprise Value to Net Income	10
Total Debt to Enterprise	0.08
Debt to Equity	0.24

Revenue Sources

No data

ESG Score

No data

About Alkermes plc